File SB987 ("Corporate Income Tax - Addition Modification - Direct-to-Consumer Pharmaceutical Advertising") is before the Maryland Legislature and has not been decided. Latest step (March 5, 2026): Hearing 3/11 at 1:00 p.m.
Maryland file SB987, before the Maryland Legislature. No action in 260 days as of 2026-03-05.
Official synopsis: Providing an addition modification under the corporate income tax for the amount of certain direct-to-consumer advertising expenses for certain covered drugs paid or incurred during the taxable year that are deducted under the Internal Revenue Code; providing for the distribution of revenue attributable to the addition modification; etc.
Read the official record for SB987
See everything up for a vote · This week in Maryland · See what we have filed with the clerk